Cancer Research Infection and Cancer: Biology, Therapeutics, and Prevention  09 AM Call for Abstracts
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 46, 5469-5472, November 1, 1986]
© 1986 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Aarbakke, J.
Right arrow Articles by Chiang, P. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Aarbakke, J.
Right arrow Articles by Chiang, P. K.

Induction of HL-60 Cell Differentiation by 3-Deaza-(±)-aristeromycin, an Inhibitor of S-Adenosylhomocysteine Hydrolase1

Jarle Aarbakke2, George A. Miura, Per S. Prytz, Atle Bessesen, Lars Slørdal, Richard K. Gordon and Peter K. Chiang

Institute of Medical Biology, University of Tromsø, N-9001 Tromsø, Norway [J. A., P. S. P., A. B., L. S.], and Division of Biochemistry, Walter Reed Army Institute of Research, Washington DC, 20307-5100 [G. A. M., R. K. G., P. K. C.]

The metabolically stable inhibitor of S-adenosylhomocysteine hydrolase (AdoHcyase), 3-deaza-(±)-aristeromycin (dzAri) has recently been shown to induce differentiation in HL-60 cells. The present study was undertaken to characterize the cytostatic, cytotoxic, and differentiation inducing properties of dzAri in HL-60 cells and to investigate biochemical consequences of AdoHcyase inhibition. A dye exclusion test and a clonogenic assay were used to test cytotoxic and cytostatic properties. dzAri had reversible cytostatic effects on HL-60 cells at concentrations lower than 10 µM and partially reversible cytotoxic effects above 10 µM. The induction of differentiation was dependent upon concentration and time of exposure, with maximal effect after 6 days incubation with 5–10 µM dzAri. Washout experiments demonstrated that the cells were not committed to differentiation after 48 h of incubation with dzAri. The AdoHcyase of HL-60 cells was inhibited with a Ki of 20 nM. The concentration of S-adenosylhomocysteine increased dose dependently 48 h after incubation with 0.1–100 µM dzAri. The incorporation of [3H]methyl from [methyl-3H]methionine into 5-methylcytosine of DNA was reduced by 26% at 5 µM dzAri. The findings indicate that continuous presence of dzAri is necessary to induce differentiation and inhibit proliferation in HL-60 cells. The inhibition of AdoHcyase perturbs levels of transmethylation metabolites and the incorporation of [3H]methyl into 5-methylcytosine of DNA.

1 This investigation was supported by grants from The Norwegian Cancer Society.

2 To whom requests for reprints should be addressed.

Received 2/24/86. Revised 6/11/86. Accepted 7/29/86.




This article has been cited by other articles:


Home page
J. Nutr.Home page
S. J. James, S. Melnyk, M. Pogribna, I. P. Pogribny, and M. A. Caudill
Elevation in S-Adenosylhomocysteine and DNA Hypomethylation: Potential Epigenetic Mechanism for Homocysteine-Related Pathology
J. Nutr., August 1, 2002; 132(8): 2361S - 2366.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
P. Yi, S. Melnyk, M. Pogribna, I. P. Pogribny, R. J. Hine, and S. J. James
Increase in Plasma Homocysteine Associated with Parallel Increases in Plasma S-Adenosylhomocysteine and Lymphocyte DNA Hypomethylation
J. Biol. Chem., September 15, 2000; 275(38): 29318 - 29323.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1986 by the American Association for Cancer Research.